Involvement of amphetamines in sudden and unexpected death

Journal of Forensic Sciences

Volumn 54, Issue 2, 2009, Pages 478-485

  Pilgrim, Jennifer L ^a   Gerostamoulos, Dimitri ^a   Drummer, Olaf H ^a   Bollmann, Marc ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

Amphetamines; Cardiovascular disease; Ecstasy; Fatal hemorrhage; Forensic science; Forensic toxicology; Multiple drug use; Serotonin syndrome; Speed; Sudden death

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; METHAMPHETAMINE; MOCLOBEMIDE;

ADULT; ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; CAUSE OF DEATH; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; FEMALE; FETAL HEMORRHAGE; FORENSIC TOXICOLOGY; HEART DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SEROTONIN SYNDROME; STATISTICAL ANALYSIS; SUDDEN DEATH;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; AUSTRALIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DEATH, SUDDEN; DRUG INTERACTIONS; FEMALE; FORENSIC PATHOLOGY; FORENSIC TOXICOLOGY; HUMANS; MALE; MIDDLE AGED; SEROTONIN SYNDROME; SUBARACHNOID HEMORRHAGE;

EID: 60849135403     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2008.00949.x     Document Type: Article

References (34)

1. Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, et al. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med 2000 133 (12 969 73.
2. Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology (Berl) 2004 173 (3-4 242 8.
3. Lyles J, Cadet JL. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Brain Res Rev 2003 42 (2 155 68.
4. Dowling GP, McDonough ET III., Bost RO. "Eve" and "Ecstasy." A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987 257 (12 1615 7.
5. Forrest AR, Galloway JH, Marsh ID, Strachan GA, Clark JC. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives. Forensic Sci Int 1994 64 (1 57 9.
6. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992 340 (8816 384 7.
7. Lora-Tamayo C, Tena T, Rodriguez A. Amphetamine derivative related deaths. Forensic Sci Int 1997 85 (2 149 57.
8. Milroy CM, Clark JC, Forrest AR. Pathology of deaths associated with "ecstasy" and "eve" misuse. J Clin Pathol 1996 49 (2 149 53.
9. Inoue H, Ikeda N, Kudo K, Ishida T, Terada M, Matoba R. Methamphetamine-related sudden death with a concentration which was of a "toxic level." Leg Med (Tokyo) 2006 8 (3 150 5.
10. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 2001 165 (7 917 28.
11. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999 44 (2 359 68.
12. Kaye S, McKetin R. Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users. National Drug and Alcohol Research Centre Technical Report No. 238. Australia : National Drug Abuse Research Centre, 2005.
13. Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007 102 : 1204 11.
14. Arimany J, Medallo J, Pujol A, Vingut A, Borondo JC, Valverde JL. Intentional overdose and death with 3,4-methylenedioxyethamphetamine (MDEA; "Eve"): case report. Am J Forensic Med Pathol 1998 19 (2 148 51.
15. De Letter EA, Piette MH, Lambert WE, Cordonnier JA. Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004. Med Sci Law 2006 46 (1 37 65.
16. Raikos N, Tsoukali H, Psaroulis D, Vassiliadis N, Tsoungas M, Njau SN. Amphetamine derivative related deaths in northern Greece. Forensic Sci Int 2002 128 (1-2 31 4.
17. Weinmann W, Bohnert M. Lethal monointoxication by overdosage of MDEA. Forensic Sci Int 1998 91 (2 91 101.
18. Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, de Boeck G, et al. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA. Clin Chem 2005 51 (10 1811 22.
19. Shaw KP. Human methamphetamine-related fatalities in Taiwan during 1991-1996. J Forensic Sci 1999 44 (1 27 31.
20. Zhu BL, Oritani S, Shimotouge K, Ishida K, Quan L, Fujita MQ, et al. Methamphetamine-related fatalities in forensic autopsy during 5 years in the southern half of Osaka city and surrounding areas. Forensic Sci Int 2000 113 (1-3 443 7.
21. Drugs and Crime Prevention Committee (DCPC). Inquiry into amphetamine and party drug use in Australia. Melbourne, Victoria, Australia : Drugs and Crime Prevention Committee, 2004-05 2005.
22. Stoové M, Jenkinson R, Cvetkovski S, Matthews S, Quinn B, Dietze P, et al. The Victorian drug statistics handbook 2006: patterns of drug use and related harm in Victoria. Melbourne, Victoria : Rural and Regional Health and Aged Care Services Division, Victorian Government Department of Human Services, 2006.
23. Drummer OH, Odell M. The forensic pharmacology of drugs of abuse. London : Arnold, 2001.
24. Drummer OH. Post-mortem toxicology. Forensic Sci Int 2007 165 (2-3 199 203.
25. National Coroners Information Service (NCIS). Report July 2000-July 2007. Melbourne, Victoria, Australia : National Coroners Information Service, 2007.
26. Baselt RC. Disposition of toxic drugs and chemicals in man. Canton, CT : Biomedical Publications, 1978.
27. Logan BK, Fligner CL, Haddix T. Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci 1998 43 (1 28 34.
28. Vuori E, Henry JA, Ojanpera I, Nieminen R, Savolainen T, Wahlsten P, et al. Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction 2003 98 (3 365 8.
29. Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL. The health effects of ecstasy: a literature review. Drug Alcohol Rev 2002 21 (1 53 63.
30. Berbatis CG, Sunderland VB, Bulsara M. Licit psychostimulant consumption in Australia, 1984-2000: international and jurisdictional comparison. Med J Aust 2002 177 (10 539 43.
31. Darredeau C, Barrett SP, Jardin B, Pihl RO. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users. Hum Psychopharmacol 2007 22 (8 529 36.
32. Kollins SH, MacDonald EK, Rush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 2001 68 (3 611 27.
33. Nissens S. ADHD drugs and cardiovascular risk. N Engl J Med 2006 354 (14 1445 8.
34. Kitzman DW, Scholz DG, Hagen PT, Ilstrup DM, Edwards WD. Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc 1988 63 (2 137 46.